Unknown

Dataset Information

0

Interaction of amyloid inhibitor proteins with amyloid beta peptides: insight from molecular dynamics simulations.


ABSTRACT: Knowledge of the detailed mechanism by which proteins such as human ?B- crystallin and human lysozyme inhibit amyloid beta (A?) peptide aggregation is crucial for designing treatment for Alzheimer's disease. Thus, unconstrained, atomistic molecular dynamics simulations in explicit solvent have been performed to characterize the A?17-42 assembly in presence of the ?B-crystallin core domain and of lysozyme. Simulations reveal that both inhibitor proteins compete with inter-peptide interaction by binding to the peptides during the early stage of aggregation, which is consistent with their inhibitory action reported in experiments. However, the A? binding dynamics appear different for each inhibitor. The binding between crystallin and the peptide monomer, dominated by electrostatics, is relatively weak and transient due to the heterogeneous amino acid distribution of the inhibitor surface. The crystallin-bound A? oligomers are relatively long-lived, as they form more extensive contact surface with the inhibitor protein. In contrast, a high local density of arginines from lysozyme allows strong binding with A? peptide monomers, resulting in stable complexes. Our findings not only illustrate, in atomic detail, how the amyloid inhibitory mechanism of human ?B-crystallin, a natural chaperone, is different from that of human lysozyme, but also may aid de novo design of amyloid inhibitors.

SUBMITTER: Das P 

PROVIDER: S-EPMC4244084 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Interaction of amyloid inhibitor proteins with amyloid beta peptides: insight from molecular dynamics simulations.

Das Payel P   Kang Seung-gu SG   Temple Sally S   Belfort Georges G  

PloS one 20141125 11


Knowledge of the detailed mechanism by which proteins such as human αB- crystallin and human lysozyme inhibit amyloid beta (Aβ) peptide aggregation is crucial for designing treatment for Alzheimer's disease. Thus, unconstrained, atomistic molecular dynamics simulations in explicit solvent have been performed to characterize the Aβ17-42 assembly in presence of the αB-crystallin core domain and of lysozyme. Simulations reveal that both inhibitor proteins compete with inter-peptide interaction by b  ...[more]

Similar Datasets

| S-EPMC1302944 | biostudies-literature
| S-EPMC6514889 | biostudies-literature
| S-EPMC6151434 | biostudies-literature
| S-EPMC4070073 | biostudies-literature
| S-EPMC4161357 | biostudies-literature
| S-EPMC2072067 | biostudies-literature
| S-EPMC8219260 | biostudies-literature
| S-EPMC2756381 | biostudies-literature
| S-EPMC2716579 | biostudies-literature
| S-EPMC7062105 | biostudies-literature